Thalys Medical Technology Hits Day Low at CNY 19.24 Amid Price Pressure

Thalys Medical Technology Group, Inc. experienced significant volatility on March 23, 2026, with the stock declining by 8.29% and reaching an intraday low of CNY 19.24. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Thalys has seen a more pronounced decline of 18.18%, while its one-month performance shows a decrease of 11.36%. Despite these short-term challenges, the company has demonstrated a notable annual performance with a gain of 64.26%, significantly outperforming the China Shanghai Composite's 13.33% increase over the same period. Financial metrics indicate that Thalys is grappling with low profitability, as evidenced by a Return on Capital Employed (ROCE) of just 2.38%. The company has also reported negative results for the last three consecutive quarters, with a net profit of CNY -72.92 million, reflecting a decline of 23.22%. The current market capitalization stands at CNY 2,098 million, categorizing Thalys as a small-cap entity within the retailing industry.